"Preliminary anti-tumor activity was observed with PSA declines in 13/16 (81.3%) of evaluable pts, and a disease control rate (stable disease ≥ 6 months) of 41.2%"
But side effects could be very hard on heavily pretreated patients
Phase 1b: FOR46, a novel antibody-dru... - Advanced Prostate...
Phase 1b: FOR46, a novel antibody-drug conjugate targeting a tumor-specific epitope of CD46, in combination with Enza in patients with mCRPC
Written by
Maxone73
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Oh guys, this one is good for mCRPC: Biologic Drug-Device Combination Immunotherapy Shows Promise for Patients with mCRPC
other two evaluable patients had stable disease at the time of data analysis. Six patients...
PHASE 3 ECLIPSE STUDY FOR (MCRPC) PATIENTS- FIRST INFUSION OF Lutetium- 177
177 was manufactured in Finland.
So far no side effects. No dry mouth, nausea, tiredness, etc....
New machine learning model could enable targeted gene therapies for genetic diseases
could one day lead to therapies to treat genetic diseases like cancer and diabetes. The model can...
ADT OR RADIATION FIRST
otherwise.I'm assuming in all depends health and disease that person may be or have become.I...
Trying to make sense of things
8 PC, high PSA and have metastatic disease, yet some with Gleason 9 and 10 have low-ish PSA (as far...
A word of Caution Concerning Ketogenic Diets
How to fight advanced pc
Filing for disability
\"Nothing Boring About Boron\" (article of interest)
